Northern Manhattan Diabetes Community Outreach Project (NOCHOP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00787475 |
Recruitment Status :
Completed
First Posted : November 7, 2008
Last Update Posted : February 4, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The objective of this study is to examine the effectiveness of a community health worker intervention at helping to control diabetes among Latinos with poorly controlled Type 2 diabetes.
Hypothesis: Compared to those in Enhanced usual care group, patients randomized to the intervention will, at 12 months, have greater reductions in: (1) HgA1C; (2) low density lipoprotein (LDL); and (3) systolic and diastolic BP.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes | Other: Community Health worker | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 360 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Prevention |
Official Title: | Northern Manhattan Diabetes Community Outreach Project |
Study Start Date : | September 2008 |
Actual Primary Completion Date : | February 2014 |
Actual Study Completion Date : | February 2014 |
Arm | Intervention/treatment |
---|---|
Experimental: 1
CHW intervention
|
Other: Community Health worker
Community Health workers with at least 4 home visits, 8 phone calls, and 10 group visits. |
No Intervention: 2
Enhanced usual care (brochure mailings)
|
- HgA1C level [ Time Frame: Up to 12 months ]
- Measurement of LDL [ Time Frame: Up to 12 months ]
- Measurement of systolic blood pressure [ Time Frame: Up to 12 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 35 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients age 35-70 years*
- Receiving care at our clinic (2 visits with a primary care provider in the previous year)
- Living in Northern Manhattan or Western Bronx (based on zip codes)
- Had a hemoglobin A1C-done within the past year, with the latest value being > or = 8.0
Exclusion Criteria:
- Patients whose primary care physician (PCP) believes are not appropriate candidates for participation
- Type 1 diabetics (identified by PCP), as their care is quite distinct from that of Type II patients, and there are very few such patients in our clinic
- Patients with diabetes diagnosed when under age 25 ("new-onset" Type I diabetes) as such patients are extremely rare in our primary care clinics
- Patients who do not self-identify as Hispanic (Hispanics can be of any race e.g. white, black, mixed)
- Any life-threatening or extreme medical co-morbidity, such as an active cancer diagnosis, paraplegia, or end stage cardio-pulmonary disease
- Having a diabetes diagnosis for < 1 year, to ensure the stability of hemoglobin A1C values above 8.0
- Planning to move out of the neighborhood during the next year
- Planning to travel out of the neighborhood for more than three consecutive months
- Enrollment in any other cardiovascular disease (CVD) or diabetes intervention study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00787475
United States, New York | |
Columbia University Medical Center | |
New York, New York, United States, 10032 |
Principal Investigator: | Walter Palmas, MD | Columbia University Medical Director |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Walter Palmas, MD, MS, FAHA, Associate Professor of Clinical Medicine, Columbia University |
ClinicalTrials.gov Identifier: | NCT00787475 |
Other Study ID Numbers: |
AAAD1689 MD00206P60 ( Other Grant/Funding Number: NIH ) |
First Posted: | November 7, 2008 Key Record Dates |
Last Update Posted: | February 4, 2015 |
Last Verified: | February 2015 |
Diabetes Community health worker Community outreach |
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |